JPRN-UMIN000014775已完成未知
Effect of Ipragliflozin, a new oral hypoglycemic agent, on body composition in patients with diabetes - Effect of Ipragliflozin on body composition
Keio University School of Medicine, Internal Medicine0 个研究点目标入组 30 人开始时间: 2014年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Contraindication for Ipragliflozin Patients who had been treated with metformin or GLP-1 analogues Pregnant woman
研究者
相似试验
已完成
不适用
Efficacy of ipragliflozin on glucose metabolismtype 2 diabetes mellitusJPRN-UMIN000013921Shiraiwa Medical Clinic10
尚未招募
不适用
Efficacy and Safety of Ipragliflozin, a selective SGLT2 inhibitor, in type 2 diabetes patients with insulin therapytype 2 diabetesJPRN-UMIN000014968Tokyo Medical University Hospital Division of Diabetes,Metabolism and Endocrinology50
已完成
不适用
The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepirideonalcoholic fatty liver disease patients with type 2 diabetesJPRN-UMIN000021291Kawasaki Medical SchoolKawasaki Medical School Devision of Diabetes, Endocrinology and Metabolism90
招募中
不适用
Efficacy of Ipragliflozin in type 1 diabetic patientstype 1 diabetic patientsJPRN-UMIN000036038Ise Red Cross Hospital Department of Metabolic Diseases50
招募中
不适用
Study of effect of oral anti-diabetic medication on cognitive function in young and middle-aged type 2 diabetes mellitus patientsCTRI/2020/02/023645Dr Vangaveti Sneha